OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti‐hyperglycaemic drug matters?
Dario Giugliano, Antonio Ceriello, Luca De Nicola, et al.
Diabetes Obesity and Metabolism (2019) Vol. 22, Iss. 2, pp. 149-157
Closed Access | Times Cited: 21
Dario Giugliano, Antonio Ceriello, Luca De Nicola, et al.
Diabetes Obesity and Metabolism (2019) Vol. 22, Iss. 2, pp. 149-157
Closed Access | Times Cited: 21
Showing 21 citing articles:
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
Dario Giugliano, Lorenzo Scappaticcio, Miriam Longo, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 187
Dario Giugliano, Lorenzo Scappaticcio, Miriam Longo, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 187
SGLT2i: beyond the glucose-lowering effect
Lihua Ni, Yuan Cheng, Guopeng Chen, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 176
Lihua Ni, Yuan Cheng, Guopeng Chen, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 176
Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials
Fabio Marsico, Stefania Paolillo, Paola Gargiulo, et al.
European Heart Journal (2020) Vol. 41, Iss. 35, pp. 3346-3358
Open Access | Times Cited: 133
Fabio Marsico, Stefania Paolillo, Paola Gargiulo, et al.
European Heart Journal (2020) Vol. 41, Iss. 35, pp. 3346-3358
Open Access | Times Cited: 133
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence
Alfredo Caturano, Raffaele Galiero, Pia Clara Pafundi, et al.
Diabetes Research and Clinical Practice (2021) Vol. 178, pp. 108959-108959
Closed Access | Times Cited: 61
Alfredo Caturano, Raffaele Galiero, Pia Clara Pafundi, et al.
Diabetes Research and Clinical Practice (2021) Vol. 178, pp. 108959-108959
Closed Access | Times Cited: 61
Efficacy of SGLT-2 inhibitors in older adults with diabetes: Systematic review with meta-analysis of cardiovascular outcome trials
Dario Giugliano, Miriam Longo, Maria Ida Maiorino, et al.
Diabetes Research and Clinical Practice (2020) Vol. 162, pp. 108114-108114
Closed Access | Times Cited: 48
Dario Giugliano, Miriam Longo, Maria Ida Maiorino, et al.
Diabetes Research and Clinical Practice (2020) Vol. 162, pp. 108114-108114
Closed Access | Times Cited: 48
Sodium–glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes
Dario Giugliano, Miriam Longo, Lorenzo Scappaticcio, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 34
Dario Giugliano, Miriam Longo, Lorenzo Scappaticcio, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 34
Applications of Clinical Decision Support Systems in Diabetes Care: Scoping Review
Shan Huang, Yuzhen Liang, Jiarui Li, et al.
Journal of Medical Internet Research (2023) Vol. 25, pp. e51024-e51024
Open Access | Times Cited: 16
Shan Huang, Yuzhen Liang, Jiarui Li, et al.
Journal of Medical Internet Research (2023) Vol. 25, pp. e51024-e51024
Open Access | Times Cited: 16
Nephroprotection by SGLT2 Inhibition: Back to the Future?
Luca De Nicola, Francis B. Gabbai, Carlo Garofalo, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 7, pp. 2243-2243
Open Access | Times Cited: 36
Luca De Nicola, Francis B. Gabbai, Carlo Garofalo, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 7, pp. 2243-2243
Open Access | Times Cited: 36
Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects
Pia Clara Pafundi, Carlo Garofalo, Raffaele Galiero, et al.
Diagnostics (2021) Vol. 11, Iss. 2, pp. 290-290
Open Access | Times Cited: 28
Pia Clara Pafundi, Carlo Garofalo, Raffaele Galiero, et al.
Diagnostics (2021) Vol. 11, Iss. 2, pp. 290-290
Open Access | Times Cited: 28
Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes
Almudena Castro Conde, Domingo Marzal Martín, Raquel Campuzano Ruiz, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 3925-3925
Open Access | Times Cited: 12
Almudena Castro Conde, Domingo Marzal Martín, Raquel Campuzano Ruiz, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 3925-3925
Open Access | Times Cited: 12
Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney
Dario Giugliano, Luca De Nicola, Maria Ida Maiorino, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 29
Dario Giugliano, Luca De Nicola, Maria Ida Maiorino, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 29
Renal protective effects of astragaloside IV, in diabetes mellitus kidney damage animal models: A systematic review, meta-analysis
Xiaotao Zhou, Junju Zou, Chun Ao, et al.
Pharmacological Research (2020) Vol. 160, pp. 105192-105192
Closed Access | Times Cited: 29
Xiaotao Zhou, Junju Zou, Chun Ao, et al.
Pharmacological Research (2020) Vol. 160, pp. 105192-105192
Closed Access | Times Cited: 29
The Role of Echocardiography in Evaluating Cardiovascular Diseases in Patients with Diabetes Mellitus
Sun Hwa Lee, Jae‐Hyeong Park
Diabetes & Metabolism Journal (2023) Vol. 47, Iss. 4, pp. 470-483
Open Access | Times Cited: 10
Sun Hwa Lee, Jae‐Hyeong Park
Diabetes & Metabolism Journal (2023) Vol. 47, Iss. 4, pp. 470-483
Open Access | Times Cited: 10
Introduction and Fundamentals of Human Islet Amyloid Polypeptide Inhibitors
Yijing Tang, Dong Zhang, Yanxian Zhang, et al.
ACS Applied Bio Materials (2020) Vol. 3, Iss. 12, pp. 8286-8308
Closed Access | Times Cited: 26
Yijing Tang, Dong Zhang, Yanxian Zhang, et al.
ACS Applied Bio Materials (2020) Vol. 3, Iss. 12, pp. 8286-8308
Closed Access | Times Cited: 26
Comparative Effects of Sodium-Glucose Cotransporter 2 Inhibitor and Thiazolidinedione Treatment on Risk of Stroke among Patients with Type 2 Diabetes Mellitus
Seung Eun Lee, Hyewon Nam, Han Seok Choi, et al.
Diabetes & Metabolism Journal (2022) Vol. 46, Iss. 4, pp. 567-577
Open Access | Times Cited: 9
Seung Eun Lee, Hyewon Nam, Han Seok Choi, et al.
Diabetes & Metabolism Journal (2022) Vol. 46, Iss. 4, pp. 567-577
Open Access | Times Cited: 9
Moving from the stratification of primary and secondary prevention of cardiovascular risk in diabetes towards a continuum of risk: need for a new paradigm
Xavier García–Moll, Vivencio Barrios, Josep Franch‐Nadal
Drugs in Context (2021) Vol. 10, pp. 1-3
Open Access | Times Cited: 5
Xavier García–Moll, Vivencio Barrios, Josep Franch‐Nadal
Drugs in Context (2021) Vol. 10, pp. 1-3
Open Access | Times Cited: 5
Changes over time in the cardiovascular risk profile of type 2 diabetes from 2007 to 2020: A community‐based study
Brent A. Williams, Jonathan P. Brady, Stephen Voyce, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 7, pp. 1216-1223
Closed Access | Times Cited: 2
Brent A. Williams, Jonathan P. Brady, Stephen Voyce, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 7, pp. 1216-1223
Closed Access | Times Cited: 2
Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus without established cardiovascular disease: Do they have a role in primary prevention?
Shailaja Kale, Abd A. Tahrani
Metabolism Open (2021) Vol. 10, pp. 100082-100082
Open Access | Times Cited: 1
Shailaja Kale, Abd A. Tahrani
Metabolism Open (2021) Vol. 10, pp. 100082-100082
Open Access | Times Cited: 1
Applications of Clinical Decision Support Systems in Diabetes Care: Scoping Review (Preprint)
Shan Huang, Yuzhen Liang, Jiarui Li, et al.
(2023)
Open Access
Shan Huang, Yuzhen Liang, Jiarui Li, et al.
(2023)
Open Access
Advantages of glucagon-like peptide-1 receptor agonists in the treatment of patients with type 2 diabetes mellitus: A review
T. Yu. Demidova, В. В. Титова, M. Ya. Izmaylova
Terapevticheskii arkhiv (2023) Vol. 95, Iss. 10, pp. 876-880
Open Access
T. Yu. Demidova, В. В. Титова, M. Ya. Izmaylova
Terapevticheskii arkhiv (2023) Vol. 95, Iss. 10, pp. 876-880
Open Access
The diminishing cost-effectiveness of the newer glucose-lowering drug classes in the United States: 2010–2018
Piaopiao Li, Rahul Patel, Jingchuan Guo, et al.
Current Medical Research and Opinion (2021) Vol. 37, Iss. 11, pp. 1875-1880
Closed Access
Piaopiao Li, Rahul Patel, Jingchuan Guo, et al.
Current Medical Research and Opinion (2021) Vol. 37, Iss. 11, pp. 1875-1880
Closed Access
